SCI Abstract

search
+
Therapeutic efficacy of Gemcitabine/Docetaxel maintenance in patients with non-muscle-invasive bladder cancer receiving initial Bacillus Calmette-Guérin induction
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Combined and individual effects of neoadjuvant chemotherapy and lymph node dissection on survival in non–muscle-invasive bladder cancer undergoing radical cystectomy
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Surgical operation duration as a predictor of venous thromboembolism risk after radical cystectomy
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Patterns of local therapy following enfortumab vedotin in advanced urothelial carcinoma
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Efficacy of disitamab vedotin-based therapy in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancer
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Is More Better? Evaluating Neoadjuvant Chemotherapy Cycles Before Surgery for High-Risk Upper Tract Urothelial Carcinoma
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenarians
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Acute kidney injury following radical nephrectomy and inferior vena cava thrombectomy: A tertiary referral center experience
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Sterotactic ablative radiotherapy vs. thermal ablation of localized renal cell carcinoma: Is there a preferred second-line management option?
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Redo partial or radical nephrectomy for solitary renal recurrence after previous nephron-sparing surgery: Is functional preservation always justified?
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Spatial immunophenotyping of tumor-associated macrophages predicts prognostic outcomes in clear cell renal cell carcinoma
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Association between presurgical physical activity and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: A prospective cohort study
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Diagnostic value of MRI-ultrasound fusion-targeted prostate biopsy for non-index lesions combined with the index lesion biopsy
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Statin use and outcomes in advanced prostate cancer:Secondary analysis of the SPARTAN trial
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
A systematic review of outcomes after prostatectomy in patients with an ileal pouch-anal anastomosis
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
A simple scoring system for predicting inguinal lymph node involvement and survival in patients with penile squamous cell carcinoma
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Cover 3 - GF 397
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Application of RNA sequencing in urologic malignancies: Advances and challenges
Starting with the discovery that genetic information is stored in the DNA, transcribed into RNA, and translated into prote...
Liquid biopsy testing in urological cancers: Focus on urine
Liquid biopsy has significantly transformed the management of patients with urological cancers. In particular, alternative...
Molecular testing in urinary cytology specimens: Current status and future directions
Bladder cancer (BCa) is the 9th most common cancer worldwide as of 2025 [[1], [2], [3]], and is generally divided into mus...
Mismatch repair deficiency testing for immune checkpoint inhibitor therapy in genitourinary malignancies
Leonid M Yermakov: Writing – review & editing, Writing – original draft, Methodology, Investigation, Formal analysis, ...
Featured SUO fellow: Daniel S. Roberson, MD
Cookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2025 Elsevier B.V., its licensors, an...
The impact of prophylactic incisional negative pressure wound therapy on surgical site infection following open radical cystectomy
In the United States, more than 10,000 radical cystectomies are performed annually, and the majority are done through an o...
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) carry a lifelong risk of recurrence and progression to ...
Sex-based differences in genetic alterations and immune checkpoint inhibitor response in urothelial bladder cancer
Bladder cancer is approximately 4 times more common in men than in women; however, women tend to present with more aggress...
Early real-world utilization of avelumab switch maintenance among patients with advanced urothelial carcinoma without progression following treatment with first-line platinum-based chemotherapy
Volume 43, Issue 10, October 2025, Pages 594.e19-594.e29Author links open overlay panel, , , , , , , , , , , , , , Highlig...
Enfortumab vedotin-related skin toxicities in patients with urothelial carcinoma: A systematic review and meta-analysis
Enfortumab vedotin (EV) is an antibody-drug conjugate (ADC) composed of a fully human monoclonal antibody that selectively...
Load More
format_indent_increase